Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT

被引：5
|
作者：
Lu, Yang [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Diagnost Imaging, Dept Nucl Med, 1400 Pressler Unit 1483, Houston, TX 77030 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2019年 / 44卷 / 11期
关键词：
multiple myeloma; lung cancer; neuroendocrine tumor; carcinoid; PET; CT; FDG; DOTATATE; NEUROENDOCRINE TUMORS; MANAGEMENT; DIAGNOSIS;
D O I：
10.1097/RLU.0000000000002706
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 69-year-old man with recurrent multiple myeloma underwent FDG PET/CT evaluation. A pulmonary nodule without higher-than-background FDG avidity was later biopsied as a low-grade neuroendocrine tumor. On further Ga-68-DOTATATE PET/CT evaluation of patient's neuroendocrine tumor, the lytic myeloma lesions revealed only mild DOTATATE avidity while the primary pulmonary neuroendocrine tumor showed intense DOTATATE uptake. The distinct imaging characteristics of different primary malignancies correlated with their underlying different pathology.
引用
收藏
页码：914 / 915
页数：2
相关论文
共 50 条
  • [1] A Case of Brown Tumor on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT
    Yao, Xilan
    Ou, Xiaohong
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : 88 - 89
  • [2] A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
    Kayani, Irfan
    Conry, Brendon G.
    Groves, Ashley M.
    Win, Thida
    Dickson, John
    Caplin, Martyn
    Bomanji, Jamshed B.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (12) : 1927 - 1932
  • [3] 68Ga-DOTATATE and 18F-FDG PET/CT in a Rapidly Progressing Lymphoma
    Parihar, Ashwin Singh
    Wahl, Richard L.
    Jahromi, Amin H.
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (01) : e64 - e65
  • [4] Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT
    Lamiaa Zidan
    Amir Iravani
    Grace Kong
    Tim Akhurst
    Michael Michael
    Rodney J Hicks
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 204 - 216
  • [5] Comparison of 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Imaging in Metastasized Merkel Cell Carcinoma
    Epstude, Maximilian
    Tornquist, Katharina
    Riklin, Christian
    di Lenardo, Francesca
    Winterhalder, Ralph
    Hug, Urs
    Strobel, Klaus
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (04) : 283 - 284
  • [6] 68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region
    Dadgar, Habibollah
    Norouzbeigi, Nasim
    Ahmadzadehfar, Hojjat
    Assadi, Majid
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (08) : E363 - E364
  • [7] Theranostic Implication of Molecular Imaging Phenotype of Well-Differentiated Lung Carcinoid by 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT
    Zidan, L.
    Iravani, A.
    Kong, G.
    Akhurst, T.
    Michael, M.
    Hicks, R.
    NEUROENDOCRINOLOGY, 2020, 110 : 280 - 280
  • [8] 68Ga-DOTATATE PET Outperforms 18F-FDG PET for Imaging Vascular Inflammation in Atherosclerosis
    Tarkin, Jason M.
    Joshi, Francis R.
    Evans, Nicholas R.
    Chowdhury, Mohammed M.
    Figg, Nichola L.
    Shah, Aarti V.
    Starks, Lakshi T.
    Manavaki, Roie
    Martin-Garrido, Abel
    Yu, Emma
    Kuc, Rhoda E.
    Kreuzhuber, Luigi Grassi Roman
    Kostadima, Myrto
    Frontini, Mattia
    Ouwehand, Willem H.
    Groves, Ashley M.
    Gopalan, Deepa
    Kirkpatrick, Peter J.
    Coughlin, Patrick A.
    Buscombe, John R.
    Fryer, Tim D.
    Bennett, Martin R.
    Warburton, Elizabeth A.
    Davenport, Anthony P.
    Rudd, James H.
    CIRCULATION, 2016, 134
  • [9] Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor
    Cheng, Zhaoting
    Zou, Sijuan
    Cheng, Siyuan
    Song, Shuang
    Zhu, Xiaohua
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (09) : 764 - 765
  • [10] 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings in a Patient With Primary Renal Well-Differentiated Neuroendocrine Tumor
    Sahin, Rahime
    Baykal Koca, Sevim
    Yucetas, Ugur
    Cermik, Tevfik Fikret
    Ergul, Nurhan
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (07) : E503 - E505
12345